<DOC>
	<DOCNO>NCT02890602</DOCNO>
	<brief_summary>This phase Ⅱ study erythropoietin management anemia cause chemotherapy patient Diffuse Large B-cell Lymphoma . The investigator want investigate hematopoietic response darbepoietin alfa quality life assessment increasement hemoglobin .</brief_summary>
	<brief_title>Erythropoietin Management Anemia Caused Chemotherapy</brief_title>
	<detailed_description>Darbepoietin alfa may cause body make red blood cell . They use treat anemia cause chemotherapy patient malignant lymphoma . Darbepoietin apply R-CHOP ( Rituximab , Cyclophosphamide , Adriamycin , Vincristine , Prednisolone ) chemotherapy every 21days ± 2days fix 360㎍ . It apply chemotherapy increment hemoglobin 12.0g/dL . If hemoglobin level exceed 12.0g/dL , administration darbepoietin temporarily stop . And , questionnaire quality life conduct baseline , 2th darbepoietin alfa administration , study completion .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Darbepoetin alfa</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>1 . Histologically confirm diffuse large B cell lymphoma treat RCHOP ( Rituximab , Cyclophosphamide , Adriamycin , Vincristine , Prednisolone ) chemotherapy 2. hemoglobin &lt; 10.0 g/dL show least 3 cycle start RCHOP ( Rituximab , Cyclophosphamide , Adriamycin , Vincristine , Prednisolone ) 3 . Currently receive plan receive least 4 time darbepoetin 4 . Age &gt; 18 year 5 . ECOG ( Eastern Cooperative Oncology Group ) performance status 02 6 . Bilirubin &lt; 2 time upper limit normal 7 . ALT ( alanine aminotransferase ) AST ( aspartate aminotransferase ) &lt; 5 time upper limit normal 8 . Creatinine &lt; 2 time upper limit normal 9 . HIV negative 10 . Ferritin &gt; 20 mcg/L ( i.e. , obviously iron deficient ) 11 . Can read Quality life measure Functional Assessment Cancer Therapy Scales Anemia 12 . Agree inform consent 1 . Received radiation therapy least 4 week start chemotherapy 2. serious preexist medical condition ( e.g. , cardiac failure [ New York Heart Association Class III IV , leave ventricular ejection fraction &lt; 50 % ] , active peptic ulceration , uncontrolled diabetes mellitus , acute diffuse infiltrative pulmonary disease ) 3. uncontrolled hypertension , define systolic blood pressure ( BP ) ≥ 180 mm Hg and/or diastolic BP ≥ 100 mm Hg , despite medical therapy 4. arrhythmia NCI CTCAE grade ≥ 2 5 . History previously treat seizure allow provided patient seizurefree minimum 3 month 6. active systemic infection require treatment , know diagnosis human HIV , active hepatitis B ( hepatitis B carrier permit ) Malignancy treat surgically local radiation therapy curative intent patient disease free &gt; 3 year 7. know hypersensitivity darbepoetin alfa 8. pregnant nursing Negative pregnancy test 9. previous diagnosis another malignancy radiographic biochemical evidence residual disease ( except completely resect basal cell carcinoma , squamous cell carcinoma skin , insitu malignancy ) 10. combine iron deficiency anemia 11. receive erythropoietin least one month start darbepoetin 12. consider autologous stem cell transplantation finish 6 cycle chemotherapy 13. untreated primary metastatic CNS ( central nervous system ) malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>